Asia
In clinical trials, Talicia demonstrated 90% efficacy in the eradication of H. pylori in studies and is the only rifabutin-based therapy on the market.
One of the things the company reported that has raised eyebrows is that the drug statistically improved cognitive function in the patients as early as week 4. This would be a very quick patient response—and for that matter, given that many Alzheimer’s studies run for years, a 36-week study is at least half the length of a typical Alzheimer’s trial.
For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.
Even clinical trial announcements don’t slow down for Halloween. It was a typically busy week. Here’s a look.
The agreement was formally signed yesterday.
“This strategic collaboration with BeiGene will enable Amgen to serve significantly more patients by expanding our presence in the world’s most populous country,” said Robert A. Bradway, Amgen’s chairman and chief executive officer.
Companies strengthen their leadership teams and boards of directors with this week’s slate of Movers & Shakers.
SGX-listed Singapore eDevelopment Limited wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. will be presenting its research on its Functional Fragrance Formula against tuberculosis at the 2020 American Society for Microbiology Biothreats Conference.
STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – announced today that its Jinshan manufacturing facility in Shanghai, China has successfully passed an inspection by the European Medicines Agency with no critical and no major findings.
Broadcast via Facebook Live from XXIV World Congress of Neurology, Dubai, UAE, Monday, Oct. 28, 7:15 am EDT
PRESS RELEASES